Table 3.
Summary of Age and Testing Schedule
| Control Group (n = 28)
| ||||
|---|---|---|---|---|
| Age (years) | Treatment Duration (days)
|
|||
| Early Monitoring Test | Final Monitoring Test | |||
| Mean | 56.0 | 44.0 | 205.9 | |
| SD | 10.5 | 10.4 | 54.4 | |
| Range | 37–80 | 29–61 | 115–297 | |
| Cisplatin Group (n = 41) | ||||
| Mean | 59.4 | 44.4 | 194.6 | |
| SD | 10.2 | 9.1 | 90.8 | |
| Range | 27–77 | 28–63 | 57–413 | |